Page last updated: 2024-08-24

oseltamivir and Allodynia

oseltamivir has been researched along with Allodynia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Souza Araújo, AA; Gasparotto, J; Gelain, DP; Guimarães, AG; Moreira, JCF; Oliveira, MA; Quintans-Júnior, LJ; Rabelo, TK; Serafini, MR1
Crain, SM; Shen, KF1

Other Studies

2 other study(ies) available for oseltamivir and Allodynia

ArticleYear
Shikimic acid inhibits LPS-induced cellular pro-inflammatory cytokines and attenuates mechanical hyperalgesia in mice.
    International immunopharmacology, 2016, Volume: 39

    Topics: Analgesics; Animals; Anti-Inflammatory Agents; Antiviral Agents; Cytokines; Hyperalgesia; Immunity, Cellular; Inflammation Mediators; Lipopolysaccharides; Macrophages; Male; Mice; Oseltamivir; p38 Mitogen-Activated Protein Kinases; RAW 264.7 Cells; Shikimic Acid; Signal Transduction

2016
Neuraminidase inhibitor, oseltamivir blocks GM1 ganglioside-regulated excitatory opioid receptor-mediated hyperalgesia, enhances opioid analgesia and attenuates tolerance in mice.
    Brain research, 2004, Jan-09, Volume: 995, Issue:2

    Topics: Acetamides; Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Drug Tolerance; Enzyme Inhibitors; G(M1) Ganglioside; Hyperalgesia; Male; Mice; Morphine; Neuraminidase; Neurons; Oseltamivir; Pain Measurement; Receptors, Opioid; Time Factors

2004